Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Follow-up of Preladenant in Parkinson's Disease
NCT00537017Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2007
- Primary completion
- Nov 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of preladenant in Parkinson's disease (PD), sponsored by Merck & Co.. Started Nov 2007; status: completed.
02
Drugs
preladenant
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00537017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537017.